New developments in guidelines for brain death/death by neurological criteria.
Journal
Nature reviews. Neurology
ISSN: 1759-4766
Titre abrégé: Nat Rev Neurol
Pays: England
ID NLM: 101500072
Informations de publication
Date de publication:
02 Feb 2024
02 Feb 2024
Historique:
accepted:
10
01
2024
medline:
3
2
2024
pubmed:
3
2
2024
entrez:
2
2
2024
Statut:
aheadofprint
Résumé
The declaration of brain death (BD), or death by neurological criteria (DNC), is medically and legally accepted throughout much of the world. However, inconsistencies in national and international policies have prompted efforts to harmonize practice and central concepts, both between and within countries. The World Brain Death Project was published in 2020, followed by notable revisions to the Canadian and US guidelines in 2023. The mission of these initiatives was to ensure accurate and conservative determination of BD/DNC, as false-positive determinations could have major negative implications for the medical field and the public's trust in our ability to accurately declare death. In this Review, we review the changes that were introduced in the 2023 US BD/DNC guidelines and consider how these guidelines compare with those formulated in Canada and elsewhere in the world. We address controversies in BD/DNC determination, including neuroendocrine function, consent and accommodation of objections, summarize the legal status of BD/DNC internationally and discuss areas for further BD/DNC research.
Identifiants
pubmed: 38307923
doi: 10.1038/s41582-024-00929-z
pii: 10.1038/s41582-024-00929-z
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Nature Limited.
Références
Mollaret, P. & Goulon, M. Le coma dépassé [French]. Rev. Neurol. 101, 3–15 (1959).
pubmed: 14423403
Vargas, F. et al. Fulminant Guillain-Barré syndrome mimicking cerebral death: case report and literature review. Intensive Care Med. 26, 623–627 (2000).
pubmed: 10923739
doi: 10.1007/s001340051213
Ravikumar, S., Poysophon, P., Poblete, R. & Kim-Tenser, M. A case of acute motor axonal neuropathy mimicking brain death and review of the literature. Front. Neurol. 7, 63 (2016).
pubmed: 27199887
pmcid: 4844925
doi: 10.3389/fneur.2016.00063
Greer, D. M. et al. Determination of brain death/death by neurologic criteria: the World Brain Death Project. JAMA 324, 1078–1097 (2020).
pubmed: 32761206
doi: 10.1001/jama.2020.11586
Greer, D. M. et al. Pediatric and adult brain death/death by neurologic criteria consensus guideline: report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM. Neurology 101, 1112–1132 (2023).
pubmed: 37821233
doi: 10.1212/WNL.0000000000207740
Lewis, A., Kirschen, M. P. & Greer, D. The 2023 AAN/AAP/CNS/SCCM pediatric and adult brain death/death by neurologic criteria consensus practice guideline: a comparison with the 2010 and 2011 guidelines. Neurol. Clin. Pract. 13, e200189 (2023).
pubmed: 37829552
doi: 10.1212/CPJ.0000000000200189
Shemie, S. D. et al. A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline. Can. J. Anaesth. 70, 483–557 (2023).
pubmed: 37131020
pmcid: 10203028
doi: 10.1007/s12630-023-02431-4
Gardiner, D. Developments in diagnosing death using neurological criteria. Crit. Eye 24, 37–39 (2023).
Choudhary, D. et al. Challenges in brain-death certification in India. Neurol. India 70, 1162–1165 (2022).
pubmed: 35864656
doi: 10.4103/0028-3886.349609
Bohatyrewicz, R. et al. Implementation of computed tomography angiography (CTA) and computed tomography perfusion (CTP) in Polish guidelines for determination of cerebral circulatory arrest (CCA) during brain death/death by neurological criteria (BD/DNC) diagnosis procedure. J. Clin. Med. 10, 4237 (2021).
pubmed: 34575352
pmcid: 8469323
doi: 10.3390/jcm10184237
Su, Y. Y. Current situation and advancement of brain death determination in China [Chinese]. Zhonghua Yi Xue Za Zhi 101, 1721–1724 (2021).
pubmed: 34167275
Guidelines for the determination of death. Report of the medical consultants on the diagnosis of death to the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. JAMA 246, 2184–2186 (1981).
Uniform Law Commission. Uniform Determination of Death Act (20_). Association of Organ Procurement Organizations, aopo.org/wp-content/uploads/Determination-of-Death-Act-20___Redline-Comparison_0623.pdf (2023).
A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to examine the definition of brain death. JAMA 205, 337–340 (1968).
An appraisal of the criteria of cerebral death. A summary statement. JAMA 237, 982–986 (1977).
Simpson, P. et al. A code of practice for the diagnosis and confirmation of death. Academy of Medical Royal Colleges. aomrc.org.uk/wp-content/uploads/2016/04/Code_Practice_Confirmation_Diagnosis_Death_1008-4.pdf (2008).
Report of special task force. Guidelines for the determination of brain death in children. American Academy of Pediatrics Task Force on Brain Death in Children. Pediatrics 80, 298–300 (1987).
Practice parameters for determining brain death in adults (summary statement). The Quality Standards Subcommittee of the American Academy of Neurology. Neurology 45, 1012–1014 (1995).
Diagnosis of brain death. Statement issued by the honorary secretary of the Conference of Medical Royal Colleges and their Faculties in the United Kingdom on 11 October 1976. Br. Med. J. 2, 1187–1188 (1976).
Guidelines for the diagnosis of brain death. Canadian Neurocritical Care Group. Can. J. Neurol. Sci. 26, 64–66 (1999).
Wijdicks, E. F. Brain death worldwide: accepted fact but no global consensus in diagnostic criteria. Neurology 58, 20–25 (2002).
pubmed: 11781400
doi: 10.1212/WNL.58.1.20
Greer, D. M., Varelas, P. N., Haque, S. & Wijdicks, E. F. Variability of brain death determination guidelines in leading US neurologic institutions. Neurology 70, 284–289 (2008).
pubmed: 18077794
doi: 10.1212/01.wnl.0000296278.59487.c2
Mathur, M. et al. Variability in pediatric brain death determination and documentation in southern California. Pediatrics 121, 988–993 (2008).
pubmed: 18450904
doi: 10.1542/peds.2007-1871
Mejia, R. E. & Pollack, M. M. Variability in brain death determination practices in children. JAMA 274, 550–553 (1995).
pubmed: 7629983
doi: 10.1001/jama.1995.03530070048028
Chang, M. Y., McBride, L. A. & Ferguson, M. A. Variability in brain death declaration practices in pediatric head trauma patients. Pediatr. Neurosurg. 39, 7–9 (2003).
pubmed: 12784069
doi: 10.1159/000070871
Wijdicks, E. F., Varelas, P. N., Gronseth, G. S. & Greer, D. M. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74, 1911–1918 (2010).
pubmed: 20530327
doi: 10.1212/WNL.0b013e3181e242a8
Nakagawa, T. A. et al. Guidelines for the determination of brain death in infants and children: an update of the 1987 Task Force recommendations. Crit. Care Med. 39, 2139–2155 (2011).
pubmed: 21849823
doi: 10.1097/CCM.0b013e31821f0d4f
Wang, H. H., Varelas, P. N., Henderson, G. V., Wijdicks, E. F. & Greer, D. M. Improving uniformity in brain death determination policies over time. Neurology 88, 562–568 (2017).
pubmed: 28077490
pmcid: 5304462
doi: 10.1212/WNL.0000000000003597
Greer, D. M. et al. Variability of brain death policies in the United States. JAMA Neurol. 73, 213–218 (2016).
pubmed: 26719912
doi: 10.1001/jamaneurol.2015.3943
Francoeur, C. et al. Variability in pediatric brain death determination protocols in the United States. Neurology 97, e310–e319 (2021).
pubmed: 34050004
doi: 10.1212/WNL.0000000000012225
Lewis, A. et al. Determination of death by neurologic criteria around the world. Neurology 95, e299–e309 (2020).
pubmed: 32576632
doi: 10.1212/WNL.0000000000009888
Lewis, A. et al. Determination of death by neurologic criteria in Latin American and Caribbean countries. Clin. Neurol. Neurosurg. 197, 105953 (2020).
pubmed: 32593465
doi: 10.1016/j.clineuro.2020.105953
Lewis, A. et al. Determination of brain death/death by neurologic criteria in countries in Asia and the Pacific. J. Clin. Neurol. 16, 480–490 (2020).
pubmed: 32657070
pmcid: 7354977
doi: 10.3988/jcn.2020.16.3.480
Hornby, K., Shemie, S. D., Teitelbaum, J. & Doig, C. Variability in hospital-based brain death guidelines in Canada. Can. J. Anaesth. 53, 613–619 (2006).
pubmed: 16738298
doi: 10.1007/BF03021854
Lewis, A. & Scheyer, O. Legal objections to use of neurologic criteria to declare death in the United States: 1968 to 2017. Chest 155, 1234–1245 (2019).
pubmed: 30935891
doi: 10.1016/j.chest.2019.03.018
Lewis, A. et al. An interdisciplinary response to contemporary concerns about brain death determination. Neurology 90, 423–426 (2018).
pubmed: 29386276
doi: 10.1212/WNL.0000000000005033
Bruce, E. N. & Cherniack, N. S. Central chemoreceptors. J. Appl. Physiol. 62, 389–402 (1987).
pubmed: 3549673
doi: 10.1152/jappl.1987.62.2.389
Lust, R. M. in xPharm: The Comprehensive Pharmacology Reference (eds. Enna, S. J. & Bylund, D. B.) https://doi.org/10.1016/B978-008055232-3.60315-0 (Elsevier, 2007).
Giani, M. et al. Apnea test during brain death assessment in mechanically ventilated and ECMO patients. Intensive Care Med. 42, 72–81 (2016).
pubmed: 26556611
doi: 10.1007/s00134-015-4105-6
Jarrah, R. J., Ajizian, S. J., Agarwal, S., Copus, S. C. & Nakagawa, T. A. Developing a standard method for apnea testing in the determination of brain death for patients on venoarterial extracorporeal membrane oxygenation: a pediatric case series. Pediatr. Crit. Care Med. 15, e38–e43 (2014).
pubmed: 24201855
doi: 10.1097/PCC.0000000000000006
Neves Briard, J. et al. Diagnostic accuracy of ancillary tests for death by neurologic criteria: a systematic review and meta-analysis. Can. J. Anaesth. 70, 736–748 (2023).
pubmed: 37155120
pmcid: 10202988
doi: 10.1007/s12630-023-02426-1
Shemie, S. D. et al. Infratentorial brain injury and death by neurologic criteria in Canada: a narrative review. Can. J. Anaesth. 70, 781–787 (2023).
pubmed: 37138155
pmcid: 10203019
doi: 10.1007/s12630-023-02427-0
Nair-Collins, M. Must hypothalamic neurosecretory function cease for brain death determination? Yes: the UDDA Revision Series. Neurology 101, 134–136 (2023).
pubmed: 37429714
doi: 10.1212/WNL.0000000000207340
Bernat, J. L. The brain-as-a-whole criterion and the Uniform Determination of Death Act. AJOB Neurosci. 14, 271–274 (2023).
pubmed: 37682673
doi: 10.1080/21507740.2023.2243889
Bernat, J. L. in Death Determination by Neurologic Criteria: Areas of Controversy and Consensus (eds Lewis, A. & Bernat, J. L.) 11–26 (Springer, 2023).
Rubin, M. A. What is the ideal brain criterion of death? Nonclinical considerations: the UDDA Revision Series. Neurology 101, 86–87 (2023).
pubmed: 37429721
doi: 10.1212/WNL.0000000000207360
Dalle Ave, A. L. & Bernat, J. L. Inconsistencies between the criterion and tests for brain death. J. Intensive Care Med. 35, 772–780 (2020).
pubmed: 29929410
doi: 10.1177/0885066618784268
Varelas, P. N. et al. The relationship between manifestation of diabetes insipidus and estimated glomerular filtration rate in brain death. Crit. Care Med. https://doi.org/10.1097/ccm.0000000000006131 (2023).
doi: 10.1097/ccm.0000000000006131
pubmed: 37966309
Lewis, A., Adams, N., Varelas, P., Greer, D. & Caplan, A. Organ support after death by neurologic criteria: results of a survey of US neurologists. Neurology 87, 827–834 (2016).
pubmed: 27449064
doi: 10.1212/WNL.0000000000003008
Lewis, A., Adams, N., Chopra, A. & Kirschen, M. P. Organ support after death by neurologic criteria in pediatric patients. Crit. Care Med. 45, e916–e924 (2017).
pubmed: 28471816
doi: 10.1097/CCM.0000000000002452
Greer, D. Should the brain death exam with apnea test require surrogate informed consent? No: the UDDA Revision Series. Neurology 101, 221–222 (2023).
pubmed: 37429710
doi: 10.1212/WNL.0000000000207333
Berkowitz, I. D. & Garrett, J. Should the brain death exam with apnea test require surrogate informed consent? Yes: the UDDA Revision Series. Neurology 101, 218–220 (2023).
pubmed: 37429709
doi: 10.1212/WNL.0000000000207343
Pope, T. M. Counterpoint: whether informed consent should be obtained for apnea testing in the determination of death by neurologic criteria? No. Chest 161, 1145–1147 (2022).
pubmed: 35526888
doi: 10.1016/j.chest.2021.11.029
Shewmon, D. A. Point: whether informed consent should be obtained for apnea testing in the determination of death by neurologic criteria? Yes. Chest 161, 1143–1145 (2022).
pubmed: 35526887
doi: 10.1016/j.chest.2021.11.026
Truog, R. D. & Tasker, R. C. Counterpoint: should informed consent be required for apnea testing in patients with suspected brain death? Yes. Chest 152, 702–704 (2017).
pubmed: 28625580
doi: 10.1016/j.chest.2017.05.032
Orliaguet, G. A., Catoire, P., Liu, N., Beydon, L. & Bonnet, F. Transesophageal echocardiographic assessment of left ventricular function during apnea testing for brain death. Transplantation 58, 655–658 (1994).
pubmed: 7940684
doi: 10.1097/00007890-199409000-00003
Nusbaum, D. M., Brady, K. M., Kibler, K. K. & Blaine Easley, R. Acute hypercarbia increases the lower limit of cerebral blood flow autoregulation in a porcine model. Neurol. Res. 38, 196–204 (2016).
pubmed: 26311295
doi: 10.1179/1743132815Y.0000000094
van Beinum, A. et al. Requests for somatic support after neurologic death determination: Canadian physician experiences. Can. J. Anaesth. 68, 293–314 (2021).
pubmed: 33174163
doi: 10.1007/s12630-020-01852-9
Russell, J. A. et al. Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statement. Neurology 92, 228–232 (2019).
pubmed: 30602465
doi: 10.1212/WNL.0000000000006750
Wahlster, S. et al. Brain death declaration: practices and perceptions worldwide. Neurology 84, 1870–1879 (2015).
pubmed: 25854866
pmcid: 4433464
doi: 10.1212/WNL.0000000000001540
National Conference of Commissioners on Uniform State Laws. Amendments to Uniform Brain Death Act, Uniform Determination of Death Act (The Conference, 1980).
Chandler J. in: Death Determination by Neurologic Criteria: Areas of Controversy and Consensus (eds Lewis, A. & Bertnat, J. L.) 305–319 (Springer, 2023).
Stewart, S., McKitty, A., Chidwick, P., Healey, A. & van Beinum, A. Trust and conflict in death determination – reflections on the legacy of Taquisha McKitty. Can. J. Anaesth. 70, 603–609 (2023).
pubmed: 37157048
pmcid: 10166452
doi: 10.1007/s12630-023-02443-0
Lewis, A. An overview of ethical issues raised by medicolegal challenges to death by neurologic criteria in the United Kingdom and a comparison to management of these challenges in the USA. Am. J. Bioeth. 24, 79–96 (2024).
pubmed: 36634197
doi: 10.1080/15265161.2022.2160516
Chandler, J. A. & Pope, T. M. Legal considerations for the definition of death in the 2023 Canadian brain-based definition of death clinical practice guideline. Can. J. Anaesth. 70, 659–670 (2023).
pubmed: 37142895
pmcid: 10202968
doi: 10.1007/s12630-023-02410-9
Lewis, A. The Uniform Determination of Death Act is being revised. Neurocrit Care 36, 335–338 (2022).
pubmed: 35102538
doi: 10.1007/s12028-021-01439-2
Lewis, A. Should the revised Uniform Determination of Death Act address objections to the use of neurologic criteria to declare death? Neurocrit Care 37, 377–385 (2022).
pubmed: 35854082
doi: 10.1007/s12028-022-01567-3
Lewis A. Perspectives of medical organizations, organ procurement organizations and advocacy organizations about revising the Uniform Determination of Death Act (UDDA). Neurocrit Care https://doi.org/10.1007/s12028-023-01872-5 (2023).